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Abstract: This study attempts to assess the effectiveness of nonpharmaceutical interventions 
towards SARS-CoV-2 infections in Germany. Using dates of infection estimated from official 
case data, exponential growth models for infections and reproduction numbers were estimated 
and investigated with respect to change points. Clear evidence is found of a decline of infections 
at the beginning of March, which can be attributed to relatively small interventions and voluntary 
behavioral changes. The effects of later interventions remain unclear. Liberalizations of 
measures did not induce a re-increase of infections. These results contradict previous studies on 
the German case. The study also exhibits three methodological challenges with respect to 
assessing of interventions: a) the estimation of true infection dates, b) the usage of several 
indicators and c) the influence of test volume. In conclusion, the effectiveness of most German 
interventions remains questionable. 
One Sentence Summary: Considering realistic infection dates, the impact of most German 
interventions towards virus spread is highly questionable. 
Main Text: Assessing the effectiveness of nonpharmaceutical interventions in the SARS-CoV-
2/COVID-19 context is a topic of growing relevance. Nevertheless, findings documenting the 
impact of these measures have not been homogeneous within the literature; whether with respect 
to single countries (1-10), or in terms of international comparisons (11-16). In this context, the 
question of whether “lockdowns” – including forced social distancing, curfews or closures of 
schools and child day care facilities – succeed or fail in reducing infections is a key concern for 
policymakers, as such measures are accompanied by serious consequences in terms of economic, 
social and psychological effects on societies (17-23). 
There have been two approaches to assessing the interventions in Germany, both of 
which focus on three bundles of measures (1. cancellation of mass events after March 8, 2. 
closure of public infrastructure such as schools, child day care facilities and nonessential services 
between March 16 and 19, and 3. contact bans and bans of gatherings from March 23). Dehning 
et al. (1) utilized epidemiological models (the SIR [susceptible-infected-recovered] model and its 
extensions) combined with Bayesian inference to find change points in infections over time with 
respect to the aforementioned measures. They identified positive effects for all three bundles of 
interventions and on this basis have explicitly outlined the importance and necessity of the 
contact ban for reducing new infections. In a series of studies (2-5), German economists 
investigated structural breaks in time series of cumulated infections and growth rates. Their 
inferred change points have been interpreted in a similar way, i.e., in support of the measures. An 
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additional modeling approach using a modified SIR model (4) also outlines the impact of the 
contact ban on infections. 
The common denominator in the approaches mentioned above (1-5) is the application of 
disease case data from the Johns Hopkins University (JHU). This data differs from the official 
German case data provided by the Robert Koch Institute (RKI) in terms of both precision and 
detail, with importantly, the latter dataset including information about the date of onset of 
symptoms for most cases (24, 25). As the interventions are aimed at reducing new infections, it 
is necessary to regard the temporal development of infections when trying to assess the success 
of any measures. Unfortunately, the true dates of infections of the reported cases are unknown 
and must be computed using the available data. Thus, the information on course of disease (as 
included in the RKI data) is essential because it helps to estimate the true infection dates. In the 
aforementioned studies, information of this type was not available, which has therefore required 
assumptions to be formulated regarding the time between infection and reporting (2-4), or 
alternatively, to estimate this time period in the model parametrization (1, 5). The SIR modeling 
study (1) has already been criticized in terms of its underestimation of this delay and the related 
results (26). 
The scope of this study is to overcome the data-related problems mentioned above. By 
using case data from the RKI (25), case-specific dates of infection are estimated. Inspired by the 
methodical approach in previous studies (2-4, 10), change points in infections were detected by 
inferring structural breaks in time series of infections in Germany from February 15 to May 29, 
2020. To ensure the validity of the analysis, significant breakpoints were inferred for three 
indicators (daily and cumulative infections as well as reproduction numbers, all of which were 
calculated based on the estimated infection dates).  
The results reveal a change point in the first third of March for all three indicators (daily 
infections: March 8 with CI [7, 9], cumulative infections: March 10 with CI [9, 11], reproduction 
number: March 3 with CI [2, 4]), which is in line with the previous studies (1-5). However, these 
results explicitly contradict other studies with respect to the strength of this change point and the 
time and strength of other breaks. Indeed, we find a trend reversal in daily infections (decline) 
already around March 8, which also represents the strongest change in growth rates of 
cumulative infections. These results thus oppose the findings of Dehning et al. (1) that a contact 
ban was necessary for a trend reversal of new infections. The influence of infrastructure closures 
can be identified with respect to reproduction numbers (March 18 with CI [17, 19]) in terms of a 
stabilization of reproduction, but importantly, not with respect to new and cumulative infections. 
Furthermore, the effects found are rather small compared to the former decrease, which is not in 
line with the former time series studies (2-5). The additional influence of the contact ban is 
highly questionable, as it does not coincide with the time this measure came into force (daily 
infections: March 29 with CI [28, 30], cumulative infections: March 25 with CI [24, 26]) and no 
corresponding break with respect to reproduction numbers was found. In the context of 
liberalizations of the measures at the end of April, change points in daily infections (April 28 
with CI [26, May 6]) and reproduction numbers (April 24 with CI [20, 27]) are found, but both 
not initiating a re-increase of infections. 
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Estimating the dates of infection is the key challenge when assessing the impact of 
nonpharmaceutical interventions 
Nonpharmaceutical governmental interventions with respect to a pandemic are aimed at reducing 
new infections (27). Thus, to assess the effectiveness of these measures, it is the dates of 
infections of the reported cases which must be regarded, rather than the date of report. However, 
the real time of infection is unknown, thus, it must be estimated using the reported cases. In 
simple terms, the time between infection and reporting consists of two time periods: a) the time 
between infection and onset of symptoms (incubation period), and b) the time between onset of 
symptoms and the date of report (reporting delay). Thus, to estimate the date of infection, both 
periods must be subtracted from the date of report (1-5, 7, 10).  
In the current medical literature, there are several estimations of the SARS-CoV-
2/COVID-19 incubation period, ranging from median values of 5.0 to 6.4 days (28-30). 
Incorporating the reporting delay, however, is much more difficult. Previous studies 
investigating the effectiveness of interventions in Germany (1-5) have employed data from the 
Johns Hopkins University (JHU) which only includes daily cases. The reporting delay is either 
assumed to be equal to 2-3 days (2-4) or estimated in the model parametrization (1, 5). In 
contrast, the data on German cases from the Robert Koch Institute (RKI) includes the reporting 
date and, for the majority of cases, case-specific dates of onset of symptoms, socio-demographic 
information (age group, gender), and the corresponding county (24, 25). If we look at the RKI 
case data of June 10, 2020 (24), there were 184,829 reported infections, for which, the date of 
onset of symptoms is known in 129,433 cases (70.03 %). The average reporting delay (time 
between onset of symptoms and case report to the RKI) equals 6.75 days (arithmetic mean; SD = 
6.19; median value equal to 5 days). Moreover, this delay varies strongly between the age groups 
of the reported cases and over time, as well as between German states (table S1). On this basis, 
we clearly see that assuming this value to be equal to 2-3 days (2-4) is a clear underestimation. 
Moreover, the obvious differences with respect to age group, time and region, indicate that it is 
difficult to assume or estimate average values for the reporting delay (1, 5). Comparing the 
cumulative cases from RKI and JHU shows an even longer reporting delay in the JHU data, at 
least until the beginning of April 2020 (figure S2). The same problem of lacking the necessary 
information for estimating infection dates also occurs when using data from the European Centre 
for Disease Prevention and Control (ECDC), as this dataset only includes daily reported cases 
and deaths as well (16). 
Obviously, the reporting delay is a key challenge in estimating the dates of infection from 
reported cases, and more critically, may potentially lead to misinterpretations of inferred change 
points in infection data. To overcome this problem, this study employs the RKI data of June 10, 
2020 (25), to estimate the true infection dates of all cases (7). For the 129,433 cases with 
reported onset of symptoms, we subtracted the incubation period from the date of onset of 
symptoms to calculate the infection date. For the 55,396 cases lacking information concerning 
the onset of symptoms, a dummy regression model based on the 129,433 cases with full 
information was estimated to interpolate the remaining reporting delays (see Materials and 
Methods). Here, the incubation period and the estimated reporting delay were subtracted from 
the date of report. In line with previous studies (1-5), the incubation period is assumed to equal 5 
days, which is the minimum value reported in the literature (28-30).  
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Detection of change points in daily and cumulative infections as well as reproduction 
numbers 
Investigating pandemic growth over time is usually conducted using epidemiological models or 
phenomenological models such as exponential or logistic growth models (31-35). Several studies 
point out that phenomenological models have the advantage that they only incorporate time 
series of infection cases, while no further assumptions concerning the transmission process of the 
disease under study (e.g., spreading rate, immunity rate, dispersion factor) are required (31, 33, 
34). Previous studies on the effectiveness of interventions have been based on an extended SIR 
model (1) or on phenomenological models for time trends (2-5, 7, 9, 10, 14). In the present case, 
interest rests on change points in the growth of infections. Thus, an exponential growth model 
has been utilized for the analysis of time series and has been estimated in its semilog form by 
Ordinary Least Squares (2-4, 10). The slope of the exponential growth model, denoted λ 
hereinafter, can be interpreted as percentage growth per time unit (36; see also Materials and 
Methods).  
Previous studies have focused on only one indicator such as daily infections (1), 
cumulative infections (2-5, 7, 9, 14), or reproduction numbers (6, 15). To arrive at a more 
holistic picture, exponential growth models were estimated for three indicators: a) the daily new 
infections, b) cumulative infections and c) the daily reproduction numbers. All these indicators 
were calculated based on estimated infection dates of COVID-19 cases from the RKI data (see 
Estimating the dates of infection). The reproduction number was computed according to the 
calculation from the German Robert Koch Institute (24; see also Materials and Methods). The 
period under study includes the infections from February 15 (first proven “super spreading 
event” in Germany, the “Kappensitzung” in Gangelt, North Rhine Westphalia) to May 29 (last 
date of infection estimated from the case data; see Estimating the dates of infection). 
Change points in the regarded variables were inferred by detecting significant structural 
breaks (breakpoints) in the time series (2-4, 10). Following this, a fluctuation test was used to 
determine whether the slopes in the (linearized) regression models, λ, remained constant or 
varied over time. The structural changes were dated, which refers to the identification of the 
specific observation(s) when the break(s) occur(s). The optimal number of breakpoints was 
inferred by the Bai-Perron algorithm for the minimization of the residual sum of squares (RSS) 
and the Bayesian Information Criterion (BIC) of the model variants (37, 38).  
Results 
Fig. 1 shows the daily infections (based on the estimated infection dates) and the daily reported 
cases from February 15 to May 29, 2020. In fig. S3, we present the estimated infections and 
reported cases on the level of calendar weeks along with additional information about the 
number of conducted SARS-CoV-2 tests (40). The maximum of daily infections occurred on 
March 11 (5,759 new infections) and calendar week 11 (34,083), respectively. The peak of 
reported cases was on April 2 (6,560 new reported cases) and calendar week 14 (36,637), 
respectively. Obviously, the time series are not simply shifted by the average delay between 
infection and report. The differences between the temporal development of both curves can be 
attributed to temporal, case-specific, and regional differences in the reporting delay (see 
Estimating the dates of infection and supplementary material). Furthermore, all results emerging 
from time series of infections shown below have to be interpreted whilst taking into 
consideration the changing number of tests conducted weekly. Specifically, we can see an 
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increase in the number of tests by a factor of 2.73 from calendar week 11 (127.457 tests) to 12 
(348,619 tests), followed by smaller fluctuations in the succeeding weeks. 
Fig. 2 shows the structural breaks in time series and corresponding model diagnostics 
(RSS and BIC) of daily infections, cumulative infections, and reproduction numbers in Germany 
from February 15 to May 29, 2020. The exponential growth rates are displayed for each segment 
(λ*100 indicates the percentage change per day). With respect to daily infections (A), we see 
three significant structural breaks on March 8 (considering statistical uncertainty in terms of 95 
% confidence intervals, resulting in an interval of March 7 to March 9, CI [7, 9]) and March 29 
(CI [28, 30]) as well as April 28 (CI [26, May 6]). The first two breaks reduce the growth rate 
from 22.8 % (February 15 to March 8) to -1.4 % (March 9 to March 29) and -5.2 % (March 30 to 
April 28), respectively (left). Thus, the number of daily new infections had already decreased 
from March 9. From April 29, the growth rate is still negative with a lower absolute value (-4.0 
%). The model solution with two breakpoints is statistically optimal as it minimizes RSS and 
BIC values (right).  
The best model solution for the cumulative infections over time (B) incorporates three 
breakpoints. The first break occurs on March 10 (CI [9, 11]), at which point the daily growth rate 
was reduced from 22.2 % to 6.8 %. The second break on March 25 (CI [24, 26]) documents a 
further decrease in growth rate (from 6.8 % to 2.0 %). The last structural change is detected on 
April 12 (CI [11, 13]), at which time the daily growth rate shifted from 2.0 % to 0.4 %. With 
respect to the reproduction number (C), three structural breaks can also be identified. After the 
first break on March 3 (CI [2, 4]), R starts to decrease by 10.0 % per day until March 18 (CI [16, 
17]). The break around March 18 initiates a stabilization (-0.6 % per day) of the R value clearly 
below one (ln R < 0). From the last change point which occurs at April 24 (CI [20, 27]), the 
reproduction number still fluctuates on a low level (daily decrease by 0.3 %).  
We find further concordant structural breaks in the temporal development for all three 
indicators in the first third of March 2020. Around March 3 to 10, the exponential growth of 
daily new infections turns from growth to decay and the growth rate of cumulative infections has 
its highest decrease. At approximately the same time, the corresponding daily reproduction 
numbers start to decrease as well. However, it should be recognized that this decline occurs 
although the test volume increased strongly in the succeeding weeks. Considering the reporting 
delay, most of the positive tests conducted in weeks 12 and 13 relate to infections in weeks 10 
and 11. Unfortunately, conducted tests cannot be linked to reported cases as both information 
stem from different data sources. However, the massive increase of testing must have had an 
influence on the detection of SARS-CoV-2 infections. It is therefore plausible to assume that if 
test volume had remained constant over time, fewer infections would have been detected and the 
decrease of (confirmed) infections would have been stronger. The decline starting in calendar 
week 12 coincides with sinking rates of positive test results from week 15 on. 
The other breakpoints are, however, not coincident: The stabilization of the reproduction 
number does not coincide neither with daily nor cumulative infections. Additionally, whilst 
structural changes in the daily and cumulative infections occur in the last third of March, there is 
no corresponding break with respect to reproduction numbers. In the last third of April, we find 
structural changes with respect to daily infections and reproduction numbers (though with a 
higher statistical uncertainty than the change points before), but the corresponding growth rates 
still remain negative. Moreover, there is no coinciding change point in cumulative infections. 
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Discussion 
We have presented a rather simple modeling approach for the development of SARS-CoV-
2/COVID-19 in Germany in terms of daily and cumulative infections as well as reproduction 
numbers over time. All three indicators were analyzed using exponential growth models and 
change points in these indicators were inferred using tests and dating of structural breaks in the 
time series. The analysis was conducted using dates of infection, which were estimated using an 
incubation period as assumed in most other studies, along with an empirical reporting delay, 
which has not been utilized in previous works. When compared with these studies (1-5), the 
present work is clearly based on the most precise information about SARS-CoV-2/COVID-19 
cases in Germany. The temporal development of the three indicators was also contrasted with 
conducted tests over time. 
Regarding all three indicators, we find consistent results with respect to a significant 
decline of infections in the first third of March – about one week before the closing of schools, 
child day care and nonessential retail facilities and two weeks before the contact ban came into 
force. This result is in line with the findings of previous studies on the German case (1-5). The 
effect coincides with the cancellation of mass events recommended by the German minister of 
health, Spahn, on March 8. However, the increased awareness in the general population could 
have also had a significant impact in terms of voluntary changes in daily behavior (e.g., physical 
distancing to strangers, careful coughing and sneezing, thorough and frequent hand washing). 
Surveys demonstrate an increased awareness towards the Corona threat in the middle of 
February and the beginning of March 2020 (41, 42). Additionally, voluntary cautious behavior in 
the Corona context could also explain the decline of other infectious respiratory diseases starting 
in the 10th calendar week, which was denoted as “abrupt” and “extremely unusual” by the 
Robert Koch Institute (43).  
The results contradict the findings of previous studies (1-5) as the change point in the 
10th calendar week is a) the clearest structural break given that it is present for all three 
indicators, b) the break which initiated a trend change in terms of a decline of virus spread and c) 
the most influential break. In the SIR modeling study (1), it is stated: “Our results indicate that 
the full extent of interventions was necessary to stop exponential growth […] Only with the third 
intervention, the contact ban, we found that the epidemic changed from growth to decay”. These 
statements are based on a negative growth rate (-3 %) having not become apparent before the 
contact ban came into force. Given the estimated infection dates in the present study, we see that 
the growth rates of new infections and reproduction numbers already turn negative on March 3 
and 8, respectively. At the same time, the growth rate of the cumulative infections has its biggest 
decrease across all four segments of the time series. Thus, a decline in infections occurred before 
school closures and the contact ban came into force. Additionally, a strong increase of test 
volume can be noted for mid-March, potentially leading to a higher rate of confirmed infections 
which occurred in the first third of March. 
In the time series studies on the German case (2-5), the closing of infrastructures (schools 
etc.) in mid-March was found to be the most influential break with respect to cumulative 
infections. We cannot confirm this conclusion, as we only find a stabilization of the reproduction 
numbers which could be attributed to this second bundle of interventions. However, we cannot 
find a referring breakpoint with respect to the new and cumulative infections. Therefore, the 
related impact remains at least questionable. The influence of the third intervention (forced social 
distancing), which was found to be the most influent factor in the SIR modeling study (1), and an 
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important factor in the previous time series analyses (2-5), remains unclear in the present study 
as well. In fact, there is no structural break in the reproduction numbers which coincides with the 
contact ban. Significant breaks in daily and cumulative infections occur after the social ban came 
into force, but not immediately, and not at the same time (March 25 and March 29, respectively). 
The mismatches between the present and previous results are obviously related to different data 
sources, a point underscored by the fact that the modeling approach is similar to some of the 
previous studies (2-4). 
The impact of liberalizations of measures (e.g., reopening of retail shops from April 20, 
reopening of schools for some age groups in the first half of May) is reflected in the temporal 
development of new infections and reproduction numbers, not with respect to cumulative 
infections. However, there is no re-increase of new infections as the corresponding growth rate 
still remains negative and the reproduction numbers remain below the critical value of one (ln R 
< 0). 
The current findings support results for Germany inferred from logistic growth models 
which show a trend change before the contact ban came into force (7). In addition, a Spanish 
study with a similar methodology revealed breakpoints in cumulative infections, with the first 
occurring about two weeks before the nationwide “lockdown” (10). Furthermore, the present 
results tend to support other studies of international comparisons which have found a decline of 
infections with or without strict interventions (11-15).  
In conclusion, clear evidence is found of a decline of SARS-CoV-2 infections in 
Germany at the beginning of March 2020, which can be attributed to relatively small 
nonpharmaceutical interventions and voluntary behavioral changes. Impacts of later measures 
are less clear because the related effects a) do not appear with respect to all three indicators, b) 
differ in strength and tend towards lower impacts, and c) occur considerably later than the 
measure came into force. The latter is particularly true for the third intervention, the contact ban. 
The additional impact of the contact ban is most questionable as it does not coincide with the 
time this measure came into force. Furthermore, liberalizations of measures did not induce a re-
increase of infections. Thus, the necessity of the second (March 16-18) and especially the third 
bundle of interventions (March 23) is questionable because a) the related effects on infections 
cannot be unequivocally validated, and b) a trend change had already occurred before they came 
into force. Furthermore, the time series of (confirmed) infections is substantially influenced by 
temporal changes in the test volume, which leads to a high degree of uncertainty with respect to 
the data source. Therefore, a future evaluation of interventions towards SARS-CoV-2/COVID-19 
in Germany should consider these questionable effects and uncertainties.  
The current approach allows for a time-related analysis of nonpharmaceutical 
interventions in Germany based on a rather simple model which does not require further 
assumptions concerning the disease under study. Thus, the methodology can be easily transferred 
to other pandemics, countries, or regions as only time series of infections are necessary. 
However, the study reveals several methodological issues for assessing the impact of 
nonpharmaceutical interventions which may influence the results enormously. Firstly, the key 
challenge is the estimation of realistic infections dates from official statistics (which typically do 
not include this information). This information is essential for the assessment of interventions as 
these measures aim at the reduction of new infections. It is particularly important to include a 
realistic and differentiated reporting delay. An underestimation of the time between infection and 
reporting leads to the estimation of infections to a later date than actually occurred in reality. As 
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a consequence, structural breaks or trend changes will also be dated too late, and thus, are 
attributed erroneously to specific interventions. Secondly, it is important to incorporate several 
indicators for the pandemic spread. Daily and cumulative infections as well as reproduction 
numbers, though based on the same initial data, have different meanings. As the results of this 
study show, significant change points may be found for some indicators but not for others. Thus, 
assessment of effectiveness of nonpharmaceutical interventions depends on the indicator used 
which leads to conclusion that the temporal development of the indicators chosen should be 
carefully compared. And lastly, quantitative investigations based on empirical case data 
implicitly assume constant test volumes, which is obviously not true. In the German case, the 
number of conducted tests for SARS-CoV-2 is not constant over time. An increase (or decrease) 
of tests may result in an artificial increase (or decrease) of reported infections. Thus, increasing 
test capacity – which is a key parameter in fighting a pandemic – may result in a statistical 
source of error when analyzing pandemics over time. All these issues exist regardless of the 
chosen modeling approach, which suggests a need to shift study design toward prioritizing the 
handling of data sources rather than refining models. 
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 Fig. 1. Infections and reported cases of SARS-CoV-2/COVID-19 in Germany, February 15 to 
May 29, 2020. The blue bars show the daily infections (based on the estimated infection dates) 
and the orange bars display the daily reported cases. The underlying data is based on own 
calculations based on the RKI case dataset from June 10, 2020 (24).   
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Fig. 2. Structural breaks in time series (left) and corresponding model diagnostics (right) of daily 
infections (A), cumulative infections (B) and reproduction number (C) in Germany from 
February 15 to May 29, 2020. On the left side, the orange lines show the daily values on the 
logarithmic scale. The structural changes are displayed by the blue vertical lines and the 
transparent blue bars show the corresponding confidence intervals. For each period, the 
exponential growth rate (λ) is shown. On the right side, the BIC (Bayesian information criterion) 
and RSS (Residual Sum of Squares) for each model variant is plotted against the number of 
structural breaks.  
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Materials and Methods 
Data source of reported SARS-CoV-2/COVID-19 cases 
The data used is the COVID-19 case data available from the Robert Koch Institute (RKI) 
online (https://npgeo-corona-npgeo-
de.hub.arcgis.com/datasets/dd4580c810204019a7b8eb3e0b329dd6_0/data) under the license 
dlde/by-2-0 (25). The file was downloaded on June 10, 2020. The dataset includes 184,829 
infections, all of which were reported before June 10, 2020, and for all of which a reporting date 
is available. From this dataset of cases, the date of onset of symptoms is known for 129,433 
cases. Furthermore, this data contains, for each individual record, information concerning age 
group, gender and region (German county).  
The time between onset of symptoms and report (reporting delay) varies across age groups, 
gender, and regions as well as over time (see table S1). The arithmetic mean is equal to 6.75 days 
(SD = 6.19) and the corresponding median equals 5 days. 95 % of the reporting delays lie 
between 0 (2.5 % percentile) and 21 (97.5 percentile) days (see fig. S2). Negative reporting 
delays occur in only a few cases. This occurs for cases in which SARS-CoV-2 tests were 
conducted prior to the onset of symptoms. Additionally, reporting errors cannot be excluded.   
 
Estimating the dates of infections 
The estimation of the true infection dates of reported cases was conducted using the 
information from the RKI case data (7). Given an assumed incubation period of 5 days for the 
records in the case dataset with known date of onset of symptoms (129,433 cases and 70.03 %, 
respectively), the date of infection of case i, DIi, is calculated as the date of onset of symptoms 
(DOi) subtracted by the incubation period (IP): 
      
𝐷𝐼𝑖 =  𝐷𝑂𝑖 − 𝐼𝑃 
 
Based on the cases with full information, a dummy variable regression model was estimated for 
the interpolation of the reporting delay for the remaining 55,396 cases. The model 
parametrization is conducted via Ordinary Least Squares (OLS) estimation. As the reporting 
delay differs across case-specific attributes, the reporting delay for case i (RDi,agc) was estimated 
by including dummy variables for age group a (a, …, A), gender g (g, …, G) and county c (c, …, 
C):  
 
𝑅𝐷𝑖,𝑎𝑔𝑐 = 𝛼 + ∑ 𝛽𝑎𝐷𝑎𝑔𝑒𝑔𝑟𝑜𝑢𝑝𝑎 + ∑ 𝛾𝑔𝐷𝑔𝑒𝑛𝑑𝑒𝑟𝑔
𝐺−1
𝑔
𝐴−1
𝑎
+ ∑ 𝛿𝑐𝐷𝑐𝑜𝑢𝑛𝑡𝑦𝑐
𝐶−1
𝑐
+ 𝜀𝑖,𝑎𝑔𝑐 
 
where α is the estimated constant, βa, and γg and δc represent sets of empirically estimated 
parameters for the A-1 age groups, G-1 gender groups and C-1 counties, and εi,agc is the 
stochastic disturbance term. The model is significant (F-statistic = 13.57 with df1 = 419 and df2 
= 114,421) at p < 0.001. The multiple R-squared is equal to 0.047 (adjusted R-squared: 0.044). 
In those cases lacking the information on onset of symptoms, the date of infection was calculated 
as the date of report (DRi) subtracted by the estimated reporting delay and the incubation period:  
 
𝐷𝐼𝑖 =  𝐷𝑅𝑖 − 𝑅𝐷𝑖,𝑎𝑔𝑐 − 𝐼𝑃 
 
Indicators for virus spread over time 
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The estimated infections dates (DIi) were summarized over days which results in the daily new 
infections at time t (IDt) and the corresponding cumulative infections at time t (I
C
t). The 
reproduction number for time t (Rt) was computed according to the calculation provided by the 
Robert Koch Institute (23) as the quotient of infections in two succeeding 4-day intervals 
(implying a generation period of 4 days): 
Rt =
∑ 𝐼𝑡
𝐷𝑡−3
𝑡
∑ 𝐼𝑡
𝐷𝑡−7
𝑡−4
 
 
Exponential growth models 
The time series of all three indicators were analyzed using exponential growth models in 
their semilog form, which means that the dependent variables (IDt, I
C
t and Rt) were transformed 
via natural logarithm. The model parametrization is conducted via Ordinary Least Squares (OLS) 
estimation. The corresponding slope parameters of the independent variable (time), here denoted 
as λ, represent the average growth rate per time unit (days) and λ*100 equals the percentage 
change per day: 
 
ln(𝐼𝑡
𝐷) = 𝛼𝐷 + 𝜆𝐷 𝑡 + 𝜇𝑡
𝐷 
 
ln(𝐼𝑡
𝐶) = 𝛼𝐶 + 𝜆𝐶  𝑡 + 𝜇𝑡
𝐶  
 
ln(𝑅𝑡) = 𝛼
𝑅 + 𝜆𝑅 𝑡 + 𝜇𝑡
𝑅 
 
where αD, αC, αR, λD, λC and λR are the parameters to be estimated and μDt, μCt and μRt represent 
the stochastic disturbance term in each model. 
 
Detection and dating of change points 
The detection and dating of change points was conducted using the breakpoints function in 
the R package strucchange (38, 39). This function incorporates a fluctuation test (recursive 
estimation test) and F statistics, which incorporates comparing the regression coefficients of a 
time series with M breakpoints (and, thus, M+1 segments) to the full sample estimates (no 
segmentation). Within these tests, structural breaks in the time series can be identified. The 
optimal number of breakpoints and their attribution to the specific observation at which point 
they occur (which means a dating of the breakpoint) was conducted using the Bai-Perron 
algorithm implemented in the breakpoints function (37, 38). The statistically optimal number of 
M breakpoints is inferred by comparing model variants with zero to five breakpoints 
(corresponding to one to six segments). The variant which minimizes the residual sum of squares 
(RSS) and the Bayesian information criterion (BIC) is considered to be the optimal solution. 
Thus, the exponential growth functions shown above are divided into M+1 segments, in which 
the regression coefficients in each m segment (m = 1, …, M+1) are constant. Confidence 
intervals (95 %) for the breakpoints were computed using the confint.breakpointsfull function 
from the strucchange package. The construction of confidence intervals for breakpoints is 
described by Bai and Perron (37). 
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Criterion Mean SD Median 
Age group 
A00-A04 5.68 5.75 4 
A05-A14 5.84 5.18 5 
A15-A34 6.68 5.79 5 
A35-A59 7.04 6.26 6 
A60-A79 7.04 6.46 6 
A80+ 5.29 6.30 4 
Unknown 9.76 8.87 7 
Gender 
Female 6.66 6.23 5 
Male 6.85 6.14 6 
Unknown/diverse 6.77 5.62 5 
Calendar week 
10 4.56 4.73 4 
11 4.45 3.85 4 
12 5.58 3.84 5 
13 7.17 4.67 7 
14 7.48 6.09 6 
15 7.00 6.50 5 
16 7.12 6.94 5 
17 7.02 7.96 5 
18 6.45 7.96 4 
19 6.25 7.87 4 
20 6.09 8.47 4 
21 5.67 8.45 4 
22 5.91 8.55 4 
23 5.86 8.96 4 
24 5.54 3.96 4 
State 
Baden-Württemberg 6.57 6.14 5 
Bayern 7.47 6.61 6 
Berlin 7.20 5.98 6 
Brandenburg 6.37 6.04 5 
Bremen 5.55 5.27 4 
Hamburg 6.32 6.92 5 
Hessen 6.91 5.91 6 
Mecklenburg-Vorpommern 5.05 4.35 4 
Niedersachsen 6.22 5.40 5 
Nordrhein-Westfalen 6.82 6.28 5 
Rheinland-Pfalz 6.87 5.79 6 
Saarland 6.93 6.24 5 
Sachsen 4.79 5.72 4 
Sachsen-Anhalt 5.11 4.84 4 
Schleswig-Holstein 6.22 6.06 5 
Thüringen 5.41 5.06 4 
All 6.75 6.19 5 
 
Table S1.  
Reporting delay (arithmetic means of time between onset of symptoms and report) for SARS-
CoV-2/COVID-19 cases in Germany by age group, gender, calendar week and state, over the 
period from February 15 to May 29, 2020.  
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Fig. S2. 
Histogram of empirical reporting delay for SARS-CoV-2/COVID-19 cases in Germany, over the 
period from February 15 to May 29, 2020. 
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Fig. S3. 
Confirmed cases (cumulative) in the datasets of Robert Koch Institute and Johns Hopkins 
University for Germany. 
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Fig. S4. 
Infections, reported cases, conducted tests and share of positive tests, over the period from the 
first reported cases (until calendar week 10) to calendar week 22.  
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Data S5. (separate file: S5_RKI_COVID19_infected.xlsx) 
Reported cases of COVID-19 based on data available from the Robert Koch Institute including 
estimated infection dates. Format: .xlsx. The original data is available here: https://npgeo-corona-
npgeo-de.hub.arcgis.com/datasets/dd4580c810204019a7b8eb3e0b329dd6_0/data (accessed June 
10, 2020) with license: dlde/by-2-0. 
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Data S6. (separate file: S6_Infections_CW.xlsx) 
Daily and cumulative infections, reproduction numbers and reported cases, as well as conducted 
SARS-CoV-2 tests, based on data available from the Robert Koch Institute. Format: .xlsx. The 
original data is available here: https://npgeo-corona-npgeo-
de.hub.arcgis.com/datasets/dd4580c810204019a7b8eb3e0b329dd6_0/data (accessed June 10, 
2020) with license: dlde/by-2-0. 
 
